GB
Gil Blum Needham Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
118
Avg Return
Past Year
Past Year
6.6%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
92.3%
Neutral
7.7%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Reiterated
| $16 |
193%
upside
| 2 | +2.7% |
0
%
| 14 Jan ‘26 5 days ago |
|
|
|
Buy
Maintained
| $3 |
369%
upside
| 2 | -9.4% |
0
%
| 13 Jan ‘26 6 days ago |
|
|
|
Buy
Maintained
| $10 |
625%
upside
| 5 | +6% |
0
%
| 12 Jan ‘26 7 days ago |
|
|
|
Buy
Maintained
| $42 |
466%
upside
| 1 | -15% |
0
%
| 9 Jan ‘26 10 days ago |
|
|
|
Buy
Reiterated
| $80 |
50%
upside
| 2 | +5.5% |
0
%
| 23 Dec ‘25 27 days ago |
|
|
|
Hold
Downgraded
| – | – | 1 | +37% |
0
%
| 19 Dec ‘25 1 month ago |
|
|
|
Buy
Reiterated
| $7 |
132%
upside
| 2 | +0.88% |
0
%
| 12 Dec ‘25 1 month ago |
|
|
|
Buy
Reiterated
| $26 |
35%
upside
| 4 | +4.8% |
0
%
| 8 Dec ‘25 1 month ago |
|
|
|
Buy
Reiterated
| $105 |
52%
upside
| 1 | -0.89% |
0
%
| 8 Dec ‘25 1 month ago |
|
|
|
Buy
Suspended
| $15 |
167%
upside
| 1 | +3.4% |
0
%
| 7 Nov ‘25 2 months ago |
|
|
|
Buy
Maintained
| $4 |
205%
upside
| 1 | -4.9% |
0
%
| 5 Nov ‘25 2 months ago |
|
|
|
Buy
Maintained
| $6 |
431%
upside
| 1 | -16% |
0
%
| 4 Nov ‘25 2 months ago |
|
|
|
Hold
Reiterated
| – | – | 1 | – |
–
| 27 Oct ‘25 2 months ago |
|
|
|
Buy
Suspended
| $6 |
61%
upside
| 1 | +44% |
0
%
| 24 Oct ‘25 2 months ago |
|
|
|
Buy
Reiterated
| $70 |
35%
downside
| 1 | +44% |
0
%
| 20 Oct ‘25 3 months ago |
|